Bellerophon Therapeutics, Inc.·4

Jan 25, 4:12 PM ET

Amin Naseem 4

4 · Bellerophon Therapeutics, Inc. · Filed Jan 25, 2019

Insider Transaction Report

Form 4
Period: 2019-01-25
Amin Naseem
Director
Transactions
  • Purchase

    Common Stock

    2019-01-25$0.70/sh+571,429$400,0001,818,867 total

Documents

1 file
  • 4
    wf-form4_154845072457175.xmlPrimary

    FORM 4